Cancer Vaccines
Inovio Biomedical Partner Tripep Provides Update on its Hepatitis C DNA Vaccine Program
Published in Hepatitis Weekly, June 4th, 2007
Inovio Biomedical Corp. (AMEX:INO), focused on the development of DNA-based vaccines for cancers and infectious diseases and a novel alternative to surgery to treat localized cancers, announced today that its partner, Tripep AB of Sweden, has provided an update regarding its application to the Swedish Medical Products Agency (MPA) to initiate a Phase I clinical trial for its proprietary DNA vaccine, ChronVac-C(R), administered using Inovio's MedPulser(R) DNA Delivery System. Tripep announced it intends to file with the MPA a modified application designed to permit clinical testing of ChronVac-C(R) in subjects already infected with hepatitis C virus instead of healthy volunteers, as per the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-06-04)
More Articles from Hepatitis Weekly
- Bird Flu
Wistar Institute Launches New Vaccine Center - Hepatitis C Virus
Could statins be a new option for hepatitis C patients? - Liver Cancer
The hepatitis C link: Diagnose, treat, transplant - Hepatitis B Virus
Agenix Completes $6.72 Million Rights Issue - Hepatitis B Virus
Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients - Hepatitis B Virus
FDA Approves Gen-Probe's Automated PROCLEIX TIGRIS System to Test Donated Blood With the PROCLEIX ULTRIO Assay - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
